Effectiveness of an Antioxidant in Preventing Restenosis After Percutaneous Transluminal Coronary Angioplasty: The Probucol Angioplasty Restenosis Trial

H Yokoi, H Daida,Y Kuwabara,H Nishikawa,F Takatsu,H Tomihara,Y Nakata,Y Kutsumi,S Ohshima,S Nishiyama,A Seki,K Kato,S Nishimura,T Kanoh,H Yamaguchi

Journal of the American College of Cardiology（1997）

引用 201|浏览7

暂无评分

摘要

Objectives. The Probucol Angioplasty Restenosis Trial was a prospective, randomized, controlled study that investigated the effectiveness of probucol therapy in reducing the rate of restenosis after percutaneous transluminal coronary angioplasty (PTCA).

查看译文

关键词

CABG,CI,HDL,LDL,Lp(a),PART,PDGF,PTCA

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要